Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR4 | P31391 | 20/20 | 0.59 |
| ▸ | SSTR1 | P30872 | 8/20 | 0.59 |
| ▸ | SSTR2 | P30874 | 6/20 | 0.57 |
| ▸ | SSTR3 | P32745 | 6/20 | 0.57 |
| ▸ | SSTR5 | P35346 | 6/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28664974 | 1.00 | SSTR4 (0.59) | SSTR4SSTR1SSTR2SSTR3SSTR5 | |
| SCHEMBL24048622 | 0.88 | SSTR4 (0.55) | SSTR4SSTR1SSTR2SSTR3SSTR5 | |
| SCHEMBL24048319 | 0.85 | SSTR4 (0.73) | SSTR4SSTR1SSTR2SSTR3SSTR5 | |
| Formic Acid SCHEMBL30448780 | 0.82 | SSTR4 (0.68) | SSTR4SSTR1SSTR2SSTR3SSTR5 | |
| Formic Acid SCHEMBL28676916 | 0.82 | SSTR4 (0.68) | SSTR4SSTR1SSTR2SSTR3SSTR5 | |
| SCHEMBL22015267 | 0.78 | SSTR4 (0.69) | SSTR4SSTR1SSTR2SSTR3SSTR5 | |
| SCHEMBL16252697 | 0.74 | SSTR4 (1.00) | SSTR4SSTR1SSTR2SSTR3SSTR5 | |
| SCHEMBL19724522 | 0.74 | SSTR4 (1.00) | SSTR4SSTR1SSTR2SSTR3SSTR5 | |
| SCHEMBL19724649 | 0.74 | SSTR4 (1.00) | SSTR4SSTR1SSTR2SSTR3SSTR5 | |
| SCHEMBL19724403 | 0.73 | SSTR4 (0.68) | SSTR4SSTR1SSTR2SSTR3SSTR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113717161-A | Nitrogen-containing saturated heterocyclic compound and preparation method, pharmaceutical composition and application thereof | 广州费米子科技有限责任公司 | 2021-11-30 | — | — | CN | disclosed |